Introduction: MS-primarily based covalent binding assays specifically measure Kinact and Ki kinetics, enabling significant-throughput Examination of inhibitor potency and binding velocity important for covalent drug progress. each and every drug discovery scientist is aware of the aggravation of encountering ambiguous facts when assessing inhibito